Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,130.00    80.00 (1.13%)
Bid:
7,110.00
Ask:
7,120.00
Spread: 10.00 (0.141%)
Market Cap: £9.56b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Interim Management Statement

2 Aug 2010 07:00

RNS Number : 2854Q
Diploma PLC
02 August 2010
 



 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

2 August 2010

 

DIPLOMA PLC

 

SECOND INTERIM MANAGEMENT STATEMENT

IN RESPECT OF YEAR ENDING 30 SEPTEMBER 2010

 

 

Diploma PLC, the international group of businesses supplying specialised technical products and services, is today issuing its second Interim Management Statement which relates to the period from 1 April 2010 to date. This follows the recent Trading Update, released on 8 July 2010.

 

Trading

The stronger trend in trading activity in most of the Group's market segments has continued during the second half of the year with revenues for the year to date, 12% ahead of the comparable period in 2009. Underlying revenues for the ten months ended 31 July 2010, after adjusting for currency effects and acquisitions, increased by ca. 8% against the comparable period last year. As the result of a continuing emphasis on control of operating costs, operating margins have improved on the same period last year.

 

In the Life Sciences sector, year to date revenues are 11% ahead of the prior year comparable period, with growth driven principally by the strong performance in the Canadian Healthcare businesses and boosted by the strength of the Canadian $ relative to UK sterling. In the European businesses, orders have increased, but these have yet to lead to a material increase in invoiced sales. Operating margins have continued to strengthen through a combination of stronger gross margins in the Canadian Healthcare businesses and the effect of prior year cost reductions in the European businesses.

 

The Seals sector businesses have seen a sharp rebound in revenues, with year to date revenues 19% ahead of the comparable period last year. The recent recovery in US industrial activity has led to a significant increase in revenues from those businesses more focused on OEM markets, such as RTD Seals and HKX. US domestic Aftermarket revenues have improved at a more modest rate, having fallen less during the recession. In Europe, Canada and other international markets, the Seals businesses have benefited from stronger industrial activity and sales have improved sharply on the comparable period last year. The same operational gearing characteristics of the Seals businesses, that led to a fall in operating margins last year, have this year contributed to a strong improvement in operating margins.

 

The Controls sector businesses have seen revenues for the year to date improve by 7% on the same period last year. The UK businesses have experienced better trading conditions in industrial markets and have benefited from a major upgrade to chilling systems by a number of UK food retailing groups. The Military Aerospace and Defence markets have remained robust, but at more subdued levels than in the first half of the year.

 

In Europe, the businesses have benefited from stronger industrial activity in Germany, with revenues continuing to show a positive trend over the comparable period last year.

 

Financial Position

The Group's cash flow generation has continued to be strong although, as anticipated at the Half Year, working capital has begun to increase in line with the increase in underlying trading activity. As at 29 July 2010, the Group's cash funds, after paying an interim dividend to shareholders of £3.2m, were in excess of £31.0m, compared with £28.4m reported at 31 March 2010.

 

The Group continues to retain a committed multicurrency credit facility of £20.0m which expires in November 2010. The Group is currently in discussions regarding replacement facilities, which should be confirmed by the year end.

 

There have been no other material changes in the position of the Group in the period since the publication of the Half Year Report for the six months ended 31 March 2010.

  

Outlook

The improving trend in revenues and operating margins will allow the Group to achieve strong progress in 2010 on the prior year.

 

In the longer term, continued progress will be dependent on a combination of a sustained recovery in the Group's key geographic markets and on the successful execution of its strategy to accelerate growth through acquisition.

 

 

 

 

Notes:

 

1. This Interim Management Statement, which is based upon unaudited management accounts, has been prepared solely to provide additional information to the shareholders of Diploma PLC in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Certain statements made in this Statement are forward-looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this Statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2. The Group's results for the year ending 30 September 2010 are expected to be released in mid November 2010.

 

3. A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

 

 

 

For further enquiries please contact:

Bruce Thompson, Chief Executive Officer

020 7549 5700

Nigel Lingwood, Group Finance Director

020 7549 5705

Simon Bloomfield, Bankside Consultants

020 7367 8861

 

 

 

NOTE TO EDITORS:

 

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

 

Diploma achieves stable growth and attractive margins from its focus on supplying specialised technical products to markets which value high levels of customer service, technical support and value adding activities. A high proportion of revenues are generated from essential products and services funded by operating, rather than capital budgets.

 

The Group employs ca. 825 employees and its principal operating businesses are located in the UK, Germany, US and Canada.

 

Over the last five years, the Group has grown adjusted earnings per share at an average of ca. 16% p.a. through a combination of organic growth and acquisitions. The current market capitalisation is ca. £285m.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEALXEDELEEFF
Date   Source Headline
1st Jun 20264:00 pmRNSAppointment of Non-Executive Director
21st May 20265:01 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSHalf Year Results
20th Apr 20265:33 pmRNSHolding(s) in Company
9th Apr 20261:16 pmRNSHolding(s) in Company
23rd Mar 20263:02 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSSignificant upgrade to FY26 guidance
27th Feb 20261:45 pmRNSAppointment of Non-Executive Director
27th Jan 20264:06 pmRNSHolding(s) in Company
16th Jan 20263:05 pmRNSDirector/PDMR Shareholding
15th Jan 202610:30 amRNSDirector/PDMR Shareholding
14th Jan 20263:53 pmRNSResult of AGM
14th Jan 20267:00 amRNSQ1 2026 Trading Update
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20251:33 pmRNSHolding(s) in Company
19th Dec 20251:33 pmRNSHolding(s) in Company
18th Dec 202510:52 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSChief Financial Officer appointment
8th Dec 20257:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20257:00 amRNSDirector/PDMR Grant of LTIP Awards
19th Nov 20252:17 pmRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSPreliminary Results
13th Nov 20257:00 amRNSIssue of Shares & Total Voting Rights
7th Oct 20257:00 amRNSDirector Declaration
2nd Oct 20252:41 pmRNSHolding(s) in Company
14th Aug 20257:00 amRNSChief Financial Officer update
17th Jul 20257:00 amRNSQ3 Trading Update
2nd Jul 20259:49 amRNSHolding(s) in Company
20th Jun 20259:50 amRNSHolding(s) in Company
9th Jun 202512:50 pmRNSHolding(s) in Company
28th May 20259:27 amRNSHolding(s) in Company
21st May 20254:07 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSHalf-year Report
19th May 202511:02 amRNSHolding(s) in Company
19th May 202510:57 amRNSHolding(s) in Company
9th May 20254:24 pmRNSHolding(s) in Company
6th May 20259:32 amRNSHolding(s) in Company
11th Apr 20253:44 pmRNSHolding(s) in Company
3rd Apr 20257:03 amRNSDirector Declaration
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20259:36 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20259:54 amRNSHolding(s) in Company
3rd Mar 202510:15 amRNSDirector Declaration - External Appointment
25th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20253:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.